- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03627247
Impact of Stress Management on Cortisol Patterns in Low-Income Pregnant Women
August 10, 2018 updated by: Guido Urizar, California State University, Long Beach
Impact of a Cognitive Behavioral Stress Management Intervention on Cortisol Regulation During Pregnancy
PROJECT NARRATIVE: As demonstrated by a growing number of studies, experiencing high levels of stress during pregnancy, including elevated levels of the stress hormone cortisol, can lead to significant long-term health problems for mothers and their infants.
The objective of the proposed research is to test whether an innovative stress management intervention, offered during pregnancy, is effective in reducing stress and cortisol levels among low-income pregnant women.
The results of the proposed work have substantial public health implications in helping to prevent the onset of stress-related health complications among mothers and their infants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
PROJECT SUMMARY: As demonstrated by a growing number of studies, stress experienced during pregnancy can lead to significant long-term health problems for mothers and their infants.
One biological mechanism that has been identified in heightening a woman's risk for developing stress-related health complications during pregnancy and the postpartum period is the stress hormone cortisol.
However, the best methods for regulating cortisol, in order to optimize maternal and infant health outcomes, have received little attention.
The objective of the proposed research is to conduct a two-arm, pilot randomized controlled study to test the efficacy of a prenatal cognitive behavioral stress management (CBSM) intervention in regulating cortisol and stress levels among low-income pregnant women.
A total of 100 women will be randomized to either a group-based, 8-week prenatal CBSM arm (i.e., cognitive coping and relaxation skills training) or a standard-of-care comparison arm (i.e., usual pre- and postnatal care) to examine whether women receiving the CBSM intervention will have significantly lower cortisol output and stress levels, relative to women randomized to the standard-of-care comparison arm.
This study will also examine whether these decreases in cortisol and stress levels are mediated through behavior change processes (e.g., increased self-efficacy and use of cognitive coping and relaxation skills).
This hypothesis has been formulated on the basis of preliminary data collected by the principal investigator and study collaborators.
Through formative research, this pilot work will develop and empirically test a prenatal CBSM stress management intervention among low-income pregnant women for use in local prenatal centers.
The results of the proposed work have substantial public health implications and are expected to advance the investigator's understanding of how pregnant women effectively use these cognitive coping and relaxation skills to adopt healthy behaviors and produce change that can positively impact their health, as well as that of their infant.
Further, the proposed research will yield a CBSM intervention that can be readily delivered in community settings, is scalable, and is relatively low cost.
Finally, these results will help identify those subgroups of pregnant women that may do particularly well (or poorly) with these innovative approaches to stress management.
This has important implications for the tailoring of CBSM programs to individual needs and preferences.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 18 years of age or older
- less than 17 weeks pregnant
- fluent in either Spanish or English
Exclusion Criteria:
- Major medical problems (e.g., gestational diabetes, major depression)
- Taking medications that may interfere with cortisol levels (e.g., asthma inhaler, antidepressants).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Behavioral Stress Management
Women randomized to CBSM participated in an eight-week prenatal course called SMART Moms (Stress Management and Relaxation Training for Moms) aimed at teaching coping and relaxation skills that address stressors and daily challenges experienced during pregnancy and motherhood.
|
Interactive activities (e.g., role-playing, use of physical props to introduce concepts related to coping and stress) were designed for each class to optimize participant engagement and understanding of the course material while tailoring class content to the stressors commonly reported by participants.
Each week, participants were given coping and relaxation skills to practice at home (e.g., cognitive reappraisal, diaphragmatic breathing) and were asked to record their experiences on an activity log that was collected and discussed in class the following week.
Course content was taught from a detailed training manual (Urizar & Kofman, 2012).
|
No Intervention: Attention Control Group
Women randomized to the AC group participated in an eight-week program where they received printed materials (offered in Spanish and English) by mail once per week, on common prenatal health information topics (e.g., common discomforts of pregnancy, labor and delivery) chosen from the March of Dimes Foundation's "Becoming a Mom" handouts (March of Dimes, 2011).
Women in this group were contacted once per week by phone by a research staff member to make sure that they received their mailed prenatal health information and to see if they had any questions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Overall Salivary Cortisol Output during Pregnancy and Early Postpartum calculated from seven saliva samples collected on one collection day at each study time point.
Time Frame: Salivary cortisol assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
The overall amount of cortisol secreted throughout the day was computed using area under the curve (AUC) in nmol/L.
Larger numbers of AUC represent a greater amount of cortisol produced throughout the day.
Elevated overall cortisol secretion throughout the day (AUC) has been associated with a number of adverse health outcomes.
Change in AUC will be examined using mixed methods models throughout each study time point.
|
Salivary cortisol assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
Change in Cortisol Awakening Response during Pregnancy and Early Postpartum calculated from seven saliva samples collected on one collection day at each study time point.
Time Frame: Salivary cortisol assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
The cortisol awakening response (CAR) was computed using the percent increase in morning cortisol in nmol/L.
CAR measures the acute rise in cortisol typically seen after waking in the morning with larger numbers representing a greater percent increase in cortisol from waking to 30 minutes after waking.
An altered CAR has been associated with a number of adverse health outcomes.
Change in CAR will be examined used mixed methods models throughout each study time point.
|
Salivary cortisol assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
Change in Diurnal Cortisol Slope during Pregnancy and Early Postpartum calculated from seven saliva samples collected on one collection day at each study time point.
Time Frame: Salivary cortisol assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
Diurnal cortisol slope was estimated by calculating the change in cortisol from waking to 8PM in nmol/L, with larger numbers representing a flatter diurnal cortisol slope (i.e., smaller decrease in cortisol levels across the day).
A flatter diurnal cortisol slope has been associated with a number of adverse health outcomes.
Change in diurnal cortisol slope will be examined using mixed methods models throughout each study time point.
|
Salivary cortisol assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Perceived Stress during Pregnancy and Early Postpartum. One total perceived stress score will be calculated using Cohen's Perceived Stress Scale, which is a questionnaire completed by participants at each study time point.
Time Frame: Perceived stress assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
Perceived stress was assessed using the 14-item version of the Perceived Stress Scale (PSS-14; Cohen & Williamson, 1988).
The PSS-14 measures the degree to which situations in one's life over the past month were appraised as stressful, with higher scores (range = 0-56) reflecting higher stress levels.
The PSS-14 has shown good test-retest reliability and internal consistency in both general and pregnancy populations (Huizink et al., 2002) and has demonstrated sensitivity to changes in the perceived stress levels of pregnant women receiving a relaxation intervention (Bastani et al., 2005).
The PSS-14 demonstrated good internal consistency across the four time points in the current study (α range = 0.74-0.75).
Change in total perceived stress will be examined used mixed methods models throughout each study time point.
|
Perceived stress assessments were conducted at baseline, during the second trimester (i.e., upon completing the eight-week program), third trimester (between 30-32 weeks of pregnancy), and at three months post partum.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Guido Urizar, PhD, California State University, Long Beach
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2010
Primary Completion (Actual)
August 30, 2014
Study Completion (Actual)
August 30, 2014
Study Registration Dates
First Submitted
July 27, 2018
First Submitted That Met QC Criteria
August 10, 2018
First Posted (Actual)
August 13, 2018
Study Record Updates
Last Update Posted (Actual)
August 13, 2018
Last Update Submitted That Met QC Criteria
August 10, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 07373610
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Due to the sensitive nature of the questions asked in this study, survey respondents were assured raw data would remain confidential and would not be shared.
Data not available / The data that has been used is confidential
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Physiological
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Centre Hospitalier Universitaire de NiceCompletedStress, Physiological
-
Texas State UniversityM. Hunter Martaindale; C. Dillard; D. GonzalezCompleted
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedPhysiological StressUnited States
-
University of UtahEnrolling by invitation
-
Ohio State UniversityCompletedStress, PhysiologicalUnited States
-
Pennington Biomedical Research CenterCompleted
-
University of Wisconsin, MadisonCompleted
-
The University of Texas Health Science Center at...RecruitingStress, Physiological | Resilience, PsychologicalUnited States
-
Pontificia Universidad Catolica de ChileWithdrawnStress, Physiological | Surgery | AnesthesiaChile
Clinical Trials on Cognitive Behavioral Stress Management
-
University of MiamiRecruitingCancer | HIV/AIDSUnited States
-
National Institute on Drug Abuse (NIDA)CompletedHIV/AIDS | Drug Abuse | Alcohol Abuse
-
National Jewish HealthCompletedDepression | Stress | Anxiety | Cystic Fibrosis | Coping SkillsUnited States
-
University of ZurichSwiss National Science FoundationCompletedHIV InfectionsSwitzerland
-
University of MiamiCompleted
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
University of British ColumbiaCompletedObsessive Compulsive DisorderCanada
-
ISA Associates, Inc.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedCancer Survivor | Young AdultUnited States